IRCT20191230045950N2招募中3 期
Comparison of Ivabradine effect versus placebo on ventricular rate in patients with non-paroxysmal atrial fibrillation under standard medical treatment
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit(—)
- 性别
- All
入选标准
- •Non-paroxysmal atrial fibrillation at randomization, with no prospect of cardioversion, anti arrhythmic treatment with group I or III drugs, or pulmonary vein ablation
- •Beta-blocker or nondihydropyridine calcium channel blocker or digoxin therapy at the maximum dose recommended for or tolerated by the patient
- •Ventricular rate of more than 70
- •Be able to voluntarily give informed consent
排除标准
- •Medical causes that explain poor heart rate control: fever, anemia, hyperthyroidism ,etc
- •Patients with a known contraindication to Ivabradine
- •Valve disease requiring surgical or percutaneous repair
- •Impossibility to attend the visits scheduled in the protocol
研究者
相似试验
已完成
不适用
The effect of ivabradine on hemodynamics in patients with chronic heart failureCirculatory SystemIschaemic cardiomyopathyChronic heart failureISRCTN87590288Faculty Hospital Olomouc (Czech Republic)50
尚未招募
Unknown
Efficacy & safety of Ivabradine versus Beta blocker in Inappropriate Sinus TachycardiaCTRI/2023/06/054179Kasturba Medical College, Manipal
进行中(未招募)
不适用
Effect of ivabradine versus placebo on cardiac function and on capacity to perform exercise in patients suffering from diastolic heart failure.Heart failure with preserved left ventricular ejection fractionMedDRA version: 18.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849EUCTR2012-002742-20-PTInstitut de Recherches Internationales Servier400
进行中(未招募)
1 期
Effect of ivabradine versus placebo on cardiac function and on capacity to perform exercise in patients suffering from diastolic heart failure.Heart failure with preserved left ventricular ejection fractionMedDRA version: 18.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849EUCTR2012-002742-20-DEInstitut de Recherches Internationales Servier400
进行中(未招募)
1 期
Effect of ivabradine versus placebo on cardiac function and on capacity to perform exercise in patients suffering from diastolic heart failure.Heart failure with preserved left ventricular ejection fractionMedDRA version: 17.0Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849EUCTR2012-002742-20-ATInstitut de Recherches Internationales Servier400
